Events

Conference: ACTIONABLE OCEAN SCIENCE 2024: The ocean we need for the future we want
NOV
Thu
14
09:30 - 12:00

This was 1 year ago

Location

Brussels

Rue Archimède 17, 1000 - Brussels
Programmes
Agro-Food, Environment Missions

On November 14, The Norwegian Institute of Marine Research welcomes you at the Norway House in Brussels to discuss the outlook and opportunities in marine research.

Here’s a summary of what to expect at this conference:

  • Learn about the latest advancements in Norwegian marine research and ocean management.
  • Gain insights into the European perspective on marine research and collaboration from Mr. Maris Stulgis of the EU.
  • Hear from project leaders involved in Mission Ocean and Waters-funded projects.

For more information and to register for this conference, please visit the dedicated page.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.